Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Lonza to sell therapeutic peptides business to PolyPeptide

Lonza has agreed to sell its therapeutic peptide business to PolyPeptide Laboratories in a deal that will also see the latter firm take on 280 staff.

Troubled Halol plant earns Sun a US FDA Form 483

The US FDA has issued Sun Pharmaceutical Industries with a Form 483 citing problems identified at its plant in Halol.

Mylan says cost cutting plan will impact up to 10% of its staff

Mylan NV has announced a restructuring plan that it says will impact less than 10% of its workforce.

US FDA says Interquim's API plant remediation plan is inadequate

The US FDA has asked Spanish API firm Interquim S.A. for more details of its plan to bring its Barcelona manufacturing plant up to code.

GSK extends single-use purification tech R&D deal with Puridify

The development partnership has been extended as GlaxoSmithKline looks to make clinical trial scale batches using Puridify’s Protein A alternative to packed bed chromatography columns.

Need-free Zika vaccine shows promise in clinical trial

As part of its collaboration with the National Institutes of Health (NIH) in the DNA vaccine clinical trial for the Zika virus, PharmaJet is providing its Stratis Needle-Free device and training to the NIH.

Indian-made fake erectile dysfunction meds seized in Switzerland en route from Serbia

Fake erectile dysfunction drugs found in Serbian coaches entering Switzerland were made in India according to regulator Swissmedic.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...